Found 170 matching trials
Response of Gut Microbiota in Type 2 Diabetes to Hypoglycemic Agents
PHASE4Intestinal microflora refers to the trillions of microorganisms living in o...
Location
Peking Union Medical College Hospital
Dapagliflozin in Active Lupus Nephritis
PHASE4Lupus nephritis is a chronic and life-threatening autoimmune cause of kidne...
Location
Massachusetts General Hospital
Effects of Dapagliflozin and Metformin on Vascular Function in Newly-Diagnosed Treatment-Naive Type 2 Diabetes
PHASE4Trial Design: This is a 12 week randomised controlled open label trial comp...
Location
Tan Tock Seng Hospital
SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
PHASE3The aim of the trial is to evaluate the effects of the SGLT2 inhibitor, dap...
Location
The George Institute for Global Health
Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation
PHASE4The purpose of this study is to investigate the effect of 2 weeks dapaglifl...
Location
Maastricht University and Medical Centre
Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.
PHASE4Randomized placebo-controlled double-blind cross-over N=1 trial in adult ma...
Location
Ziekenhuisgroep Twente
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
PHASE2The study aims to determine the short-term efficacy, mechanisms and safety ...
Location
Toronto General Hospital
Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 Diabetes
PHASE3The purpose of this study is to learn if a combination of BMS-477118 (Saxag...
Location
Central Alabama Research
Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy
NAThe goal of this research study is to further understand the physiological ...
Location
University of Edinburgh
Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects
PHASE4New strategies trying to achieve blood pressure control and consequently re...
Location
University of Campinas (UNICAMP)